Accretion Pharmaceuticals Other Announcement
Accretion Pharmaceuticals Limited submitted its Regulation 74(5) compliance certificate for the quarter ended March 31, 2026. The certificate from RTA KFin Technologies confirms that all company shares are in dematerialized form and no rematerialization requests were received during the period.